Recent advances in idiopathic pulmonary fibrosis (IPF) continue to expand the evidence base, offering important insights into disease biology, therapeutic strategies, and ongoing research. However, clinicians often face challenges in interpreting and applying these insights within the context of evolving IPF care.

In this What's New Doc video, Dr. Steven Nathan reviews the latest clinical trial findings, real-world evidence, and scientific advances shaping the evolving understanding of IPF. By translating emerging data into practical clinical insights, he discusses their impact on disease management, treatment decisions, and the future direction of IPF care in 2026.

Launch/Release Date: July 9, 2026

Activity Expiration Date: June 30, 2027

FACULTY

Steven Nathan, MD

Schar Chair

Medical Director, Advanced Lung Disease and Transplant Program

Inova Fairfax Hospital

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Despite progress in disease identification and treatment strategies, PAH continues to carry considerable morbidity and mortality, highlighting the need for continued optimization of disease management.

Throughout this educational podcast, Dr. Vallerie McLaughlin highlights the latest advances in PAH presented at the International 2026 Conference in Orlando, FL.

Launch Date/Release Date: May 21 2026

Expiration Date: April 30, 2027

FACULTY

Vallerie McLaughlin, MD

Kim A. Eagle, MD Endowed Professor of Cardiovascular Medicine

University of Michigan Medical School

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

In this expert-led podcast, Dr. Nathan shares practical insights on recognizing early indicators of PH in the setting of ILD, interpreting key diagnostic findings, and applying effective risk stratification strategies. The discussion focuses on improving early detection and optimizing management to ultimately enhance outcomes for this high-risk patient population.

Launch Date/Release Date: May 7, 2026

Expiration Date: April 30, 2027

FACULTY

Steven Nathan, MD

Schar Chair

Medical Director, Advanced Lung Disease and Transplant Program

Inova Fairfax Hospital

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.